Nov 12 2015 Relmada Therapeutics Strengthens its Board of Directors with the Appointment of Maged Shenouda and Paul Kelly View
Sep 09 2015 Relmada Therapeutics Announces Issuance of U.S. Patent Covering SECUREL™ - an Abuse-Deterrent, Extended-Release, Technology Platform for Opioids View
Aug 17 2015 Relmada Therapeutics Receives Health Canada Clearance to Commence Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist View
Aug 12 2015 Relmada Therapeutics Announces Launch of New Website and Corporate Communication Channels View
